Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy
- PMID: 33305002
- PMCID: PMC7709512
- DOI: 10.1136/bmjophth-2020-000540
Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy
Abstract
Objective: To investigate the factors affecting the duration of subretinal fluid (SRF) resolution and their correlation with the final anatomical and functional outcome in cases of treatment naïve acute central serous chorioretinopathy (CSCR).
Methods and analysis: We retrospectively studied 93 eyes of 93 patients diagnosed with treatment naïve acute CSCR presenting within 30 days of onset of symptoms. The eyes were divided into two groups (1 and 2) based on the duration of SRF resolution; which was ≤3 months in group 1 and >3 months in group 2. Demographic and medical history, and spectral domain optical coherence tomography features were noted and their association with duration for SRF resolution, final central macular thickness (CMT) and final best-corrected visual acuity (BCVA) were studied. All the patients were prescribed topical non-steroidal anti-inflammatory drug for 1 month at the diagnosis of CSCR.
Results: Longer duration of symptoms, female gender and baseline OCT factors like hyper-reflective dots and retinal pigment epithelial bumps were associated with longer duration for SRF resolution (p<0.001, p=0.04, p=0.001 and p=0.01, respectively). The SRF resolution time had strong correlations with the final CMT (r=-0.589, p<0.001) and final BCVA in logarithm of minimum angle of resolution (LogMAR) (r=+0.599, p<0.001). Group 2 eyes had worse final BCVA and thinner final CMT than Group 1 (both p<0.001). The final CMT of the patients of Group 1 was statistically thinner than the normal population (p<0.001).
Conclusion: Patient's baseline clinicodemographic and OCT features can be used to predict the course and visual outcome in cases of treatment naïve acute idiopathic CSCR.
Keywords: retina.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.Ophthalmol Ther. 2023 Feb;12(1):517-533. doi: 10.1007/s40123-022-00625-5. Epub 2022 Dec 12. Ophthalmol Ther. 2023. PMID: 36510030 Free PMC article.
-
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.Eur J Ophthalmol. 2022 Jul;32(4):2319-2327. doi: 10.1177/11206721211055018. Epub 2021 Nov 6. Eur J Ophthalmol. 2022. PMID: 34747194
-
Short Term Presence of Subretinal Fluid in Central Serous Chorioretinopathy Affects Retinal Thickness and Function.J Clin Med. 2020 Oct 26;9(11):3429. doi: 10.3390/jcm9113429. J Clin Med. 2020. PMID: 33114519 Free PMC article.
-
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy.J Clin Med. 2019 Aug 22;8(9):1271. doi: 10.3390/jcm8091271. J Clin Med. 2019. PMID: 31443376 Free PMC article.
-
Baseline Predictive Factors of Visual Outcome and Persistence of Subretinal Fluid Based on Morphologic Changes in Spectral Domain Optical Coherence Tomography in Patients with Idiopathic Central Serous Chorioretinopathy.Clin Ophthalmol. 2019 Dec 9;13:2439-2444. doi: 10.2147/OPTH.S233273. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31849441 Free PMC article.
Cited by
-
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy.Sci Rep. 2024 Oct 18;14(1):24424. doi: 10.1038/s41598-024-75506-x. Sci Rep. 2024. PMID: 39424890 Free PMC article.
-
Association of Subretinal Fluid Duration and Baseline Chorioretinal Structure With Optical Coherence Tomography in Central Serous Chorioretinopathy.Transl Vis Sci Technol. 2023 Oct 3;12(10):12. doi: 10.1167/tvst.12.10.12. Transl Vis Sci Technol. 2023. PMID: 37831445 Free PMC article.
-
Effects of Ketoconazole on the Clinical Recovery in Central Serous Chorioretinopathy.Clin Ophthalmol. 2022 Jun 9;16:1871-1882. doi: 10.2147/OPTH.S368427. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35711967 Free PMC article.
References
-
- Donald J, Gass M. Pathogenesis of disciform detachment of the neuroepithelium: II. idiopathic central serous choroidopathy. Am J Ophthalmol 1967;63:1. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous